Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Issue of Equity

16 Nov 2009 18:18

RNS Number : 5997C
Croma Group PLC
16 November 2009
 



Croma Group PLC

Issue of equity and directors' dealings 

The Board of Croma Group PLC ("Croma" or the "Company") announces that, on 16 November 2009, it issued and allotted 6,500,000 new ordinary shares of 0.1 pence each ("New Ordinary Shares") (representing approximately 3.66 per cent. of the current issued share capital of the Company) at a price of 2.0 pence per share (the "Subscription Price"), to directors raising £130,000 (before expenses) pursuant to a subscription. The net subscription proceeds will be used for the repayment of debt. 

The New Ordinary Shares are being subscribed for under existing authorities to issue and allot shares. 

Application has been made to the London Stock Exchange for the 6,500,000 New Ordinary Shares to be admitted to trading on AIM and it is expected that dealings will commence on or around 20 November 2009. 

Directors' dealings 

Pursuant to the subscription, Sebastian Morley, a director of the Company, has subscribed for 2,500,000 New Ordinary Shares at the Subscription Price. Following this transaction, Sebastian Morley's beneficial interest in the Company is 21,028,634 ordinary shares, representing approximately 11.44 per cent. of the enlarged issued share capital of the Company. 

Gerald McGill, a director of the Company, has subscribed for 500,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, Gerald McGill's beneficial interest in the Company is 1,250,000 ordinary shares, representing approximately 0.68 per cent. of the enlarged issued share capital of the Company. 

James Sullivan, a director of the Company, has subscribed for 1,000,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, James Sullivan's beneficial interest in the Company is 1,000,000 ordinary shares, representing approximately 0.54 per cent. of the enlarged issued share capital of the Company. 

Furthermore, Nicholas Hewson, a director of the Company, has subscribed for 2,500,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, Nicholas Hewson's beneficial interest in the Company is 6,354,342 ordinary shares, representing approximately 3.46 per cent. of the enlarged issued share capital of the Company. 

Total Voting Rights

In accordance with FSA's Disclosure and Transparency Rules, the Company advises that its increased issued share capital comprises 183,883,964 ordinary shares of 0.1 pence each. The voting rights of all of these shares are identical with each share carrying the right to one vote. The Company holds no ordinary shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Croma Group Plc under the Disclosure and Transparency Rules.

For further information contact:

Croma Group PLC:

Sebastian Morley, CEO

Tel: 07768 006909

Brewin Dolphin:

Sandy Fraser, Managing Director - Corporate Finance (NOMAD)

Tel: 0845 213 2072

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBFBPTMMBBBPL
Date   Source Headline
5th Nov 20157:00 amRNSFinal Results
14th Sep 20157:00 amRNSNew Contract Wins
1st Jul 20157:00 amRNSContract Win
9th Jun 20157:00 amRNSNew Contract Wins
26th Feb 20157:01 amRNSInterim Results
3rd Dec 20146:01 pmRNSResult of AGM and Dividend Declaration
6th Nov 20147:00 amRNSFinal Results for the year to 30 June 2014
31st Jul 20147:00 amRNSTrading Update
27th Feb 20146:15 pmRNSReplacement : INTERIM RESULTS
27th Feb 20147:00 amRNSINTERIM RESULTS
31st Jan 20147:00 amRNSDirectorate Change
30th Dec 20135:04 pmRNSDirector Shareholding
11th Dec 20132:36 pmRNSResult of AGM
14th Nov 20137:00 amRNSFinal Results for the year to 30 June 2013
7th May 20137:00 amRNSDirectors Dealing & Issue of Equity
29th Apr 20134:21 pmRNSDirector Shareholding
29th Apr 201310:12 amRNSDirector Shareholding
29th Apr 20139:37 amRNSDirector Shareholding
26th Apr 20131:44 pmRNSTrading Update
3rd Apr 20137:00 amRNSContract Renewal
15th Mar 20137:00 amRNSInterim Results
2nd Jan 20138:36 amRNSResult of AGM
10th Dec 20127:00 amRNSPosting of Annual Report and Notice of AGM
10th Dec 20127:00 amRNSContract Win
5th Nov 201210:09 amRNSReplacement: Contract wins with Odeon and UK Land
5th Nov 20127:01 amRNSContract wins with Odeon Cinemas and UK Land Plc
5th Nov 20127:00 amRNSPreliminary Results
10th Sep 20127:00 amRNSFastvein System Deployed During Olympic Sailing
28th Jun 20127:00 amRNSAppointment of Finance Director
26th Jun 20127:00 amRNSOdeon Contract Win
18th Jun 20127:00 amRNSNew Contract Win
1st Jun 20127:00 amRNSChange of Adviser
23rd May 20129:10 amRNSContract Win
16th May 20122:12 pmRNSDirector Shareholding
11th May 201212:17 pmRNSDirector/PDMR Shareholding
30th Apr 20126:00 pmRNSDirector/PDMR Shareholding
27th Apr 20127:00 amRNSResults of Subsidiaries
18th Apr 20127:00 amRNSDirector's Biography
17th Apr 201211:42 amRNSChange of Registered Office
2nd Apr 20121:13 pmRNSDirector/PDMR Shareholding
30th Mar 201211:07 amRNSHolding(s) in Company
29th Mar 20125:24 pmRNSIssue of Equity
29th Mar 20123:40 pmRNSHolding(s) in Company
29th Mar 20121:50 pmRNSHolding(s) in Company
29th Mar 20127:00 amRNSHolding(s) in Company
27th Mar 20128:00 amRNSRe-admission to Trading
26th Mar 201210:42 amRNSResult of General Meeting
26th Mar 201210:35 amRNSResult of General Meeting
1st Mar 201212:00 pmRNSUpdate on Reverse Acquisition
1st Mar 201211:51 amRNSSchedule 1 - Croma Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.